| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
Luveris is owned by Emd Serono.
Luveris contains Lutropin Alfa.
Luveris has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Luveris are:
- US5767251
Luveris was authorised for market use on 08 October, 2004.
Luveris is available in injectable;subcutaneous dosage forms.
The generics of Luveris are possible to be released after 16 June, 2015.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Oct 08, 2011 |
Drugs and Companies using LUTROPIN ALFA ingredient
Market Authorisation Date: 08 October, 2004
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
LUVERIS family patents
